Pre-Filled Syringes – Chemical Compatibility and Design Strategies

On Feb 20, 2019

At SMi’s 2019 Pre-Filled Syringes East Coast USA Conference, industry leaders will meet in Boston to share their insights on best design practice, drug compatibility within the whole supplier chain and challenges with manufacturing and drug delivery.

Key highlights include:

Cyclo Olefin Polymer (COP) – technical data update

Key properties of COP
Case study. Biologics formulation for COP syringe optimized to eliminating use of surfactant
Case study. Study on protein adsorption/aggregation – COP vs glass
Case study. Study on delamination with glass syringe vs COP syringe
Leachable data on COP syringes with various chemicals

KEYNOTE ADDRESS
Control strategy and design transfer for pharmaceutical delivery device combination products

Establish control strategy (CS) for PFS manufacturing including device constituent parts
Develop CS for delivery device during design transfers to identify critical quality attributes (CQAs) for device constituent parts
Generate a set of controls, e.g. incoming, in-process, release and/or stability specifications for delivery device manufacturing
Promote communication between device and drug development groups, development and manufacturing groups, pharma company and device component suppliers
Recognize the difference between delivery device and drug: drug focused more on process parameter (e.g. CPP) and device focused more on material attributes (e.g. CMA)

The best plastic syringe for biologics

Multilayer plastic vial & syringe
Excellent oxygen and UV barrier contribute to stability of drugs
Very low extractables contribute to stability of drugs
Minimized silicone-oil contributes to preventing protein aggregation

PFS / autoinjector compatibility – impacts to manufacturing and drug delivery performance

What is the PFS/Autoinjector compatibility?
Challenges to manufacturing and drug delivery performance
Proposed solutions

Speakers include:
Toshiro Katayama, Product Manager, Zeon
Ling Lu, Sr. Principal Scientist, Pfizer
Shota Arakawa, Business Development Researcher, Mitsubishi Gas Chemical Company
Joyce Y Zhao, Device Lead, Combination Product Development, Takeda

More details are available at the website http://www.pfsamericas.com/pr5

West Pharmaceutical Services | ZEON

Contacts:

Sponsorship, exhibition and branding packages: Alia Malick +44 (0)20 7827 6168 / amalick@smi-online.co.uk
Delegate enquiries: Kieran Ronaldson on +44 (0) 20 7827 6744 / kronadlson@smi-online.co.uk
Media enquiries contact Neill Howard +44 (0) 207 827 6164 nhoward@smi-online.co.uk

————————————————————————————

About SMi Group:

Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the world’s most forward-thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at http://www.smi-online.co.uk